- Q4 2023 HALEON PLC Pre-Recorded Earnings Presentation TranscriptFeb 29, 2024
- Q4 2023 HALEON PLC Earnings Call TranscriptFeb 29, 2024€3.93 (+5.63%)Earnings
- HALEON PLC first Haleon Oral Health TranscriptDec 07, 2023
- Q3 2023 HALEON PLC Trading Statement Call TranscriptNov 02, 2023
- Half Year 2023 HALEON PLC Earnings Call TranscriptAug 02, 2023€3.76 (-3.23%)Earnings
- Half Year 2023 HALEON PLC Earnings Presentation (Pre-recorded) TranscriptAug 02, 2023
- HALEON PLC at Exane CEO Conference TranscriptJun 08, 2023
- Q1 2023 HALEON PLC Trading Statement Call TranscriptMay 03, 2023
- Haleon PLC Fireside Chat with Societe Generale SA TranscriptMar 23, 2023
- Full Year 2022 HALEON PLC Earnings Call (Q&A) TranscriptMar 02, 2023€3.56 (-2.73%)Earnings
- Full Year 2022 HALEON PLC Earnings Presentation (Pre-Recorded) TranscriptMar 02, 2023
- HALEON PLC at Redburn CEO Conference TranscriptNov 30, 2022
- Q3 2022 HALEON PLC Trading Statement Call TranscriptNov 10, 2022
- HALEON PLC at Sanford C Bernstein Pan European Strategic Decisions Conference TranscriptSep 28, 2022
- Half Year 2022 HALEON PLC Earnings Presentation (Pre-recorded) TranscriptSep 20, 2022
- Half Year 2022 HALEON PLC Earnings Call (Q&A) TranscriptSep 20, 2022€2.98 (-0.17%)Earnings
- HALEON PLC at Deutsche Bank dbAccess Global Consumer Conference TranscriptJun 14, 2022
- HALEON PLC at JPMorgan CEO Call Series TranscriptMay 20, 2022
- HALEON PLC at UBS Global Consumer & Retail Conference (Virtual) TranscriptMar 09, 2022
- GlaxoSmithKline PLC and HALEON PLC Consumer Healthcare Capital Markets Day TranscriptFeb 28, 2022
- HALEON PLC at UBS European Conference (Virtual) TranscriptNov 09, 2021
- HALEON PLC at Exane BNP Paribas European CEO Conference TranscriptJun 10, 2021
Haleon PLC Fireside Chat with Societe Generale SA Transcript
Good morning, everyone. Great to have you all on the line. I'm really pleased to introduce to Tobias Hestler, CFO of Haleon, who's with us today to run through our questions, as well as those submitted in advance by some of you on the line. So we've got about 50 minutes, so I suggest we just dive right in.
Thank you for joining us. If we can start with the outlook for top line at group level before delving down into some of the categories, your midterm sales growth target of 4% to 6% implies outperformance versus your expectations for growth of the consumer health care market of around 3% to 4%. And the midpoint of that range suggests market share is expected to grow by around 50 basis points or so over the next few years.
Can you sort of help us understand whether this outperformance is expected to come more from share gains in existing market? Or is new market entry a bigger element of that?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)